The conflict-of-interest policies for the Journal of the American Medical Association and "policies applied to industry-sponsored studies" published in the journal "are more stringent than those of any other leading medical journal in the world," Catherine DeAngelis, editor in chief of JAMA, and Phil Fontanarosa, executive deputy editor of JAMA, write in a New York Times letter to the editor. In response to a July 23 Times editorial, DeAngelis and Fontanarosa write, "We strongly object to your characterization of JAMA as a "'conflicted medical journal,' and to your unfair association of JAMA with an incident at the journal Neuropsychopharmacology." They add that JAMA has made a "deliberate, bona fide, proactive and unrelenting effort to ensure that physicians and patients can properly interpret and trust what they read" in the journal (DeAngelis/Fontanarosa, New York Times, 7/29).

"Reprinted with permission from kaisernetwork. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at kaisernetwork/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.